Group One Trading
CDMO

Group One Trading’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Group One Trading’s Portfolio CDMO Stock Details CDMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-40,900
Closed -$505K – 8584
2024
Q4 		$505K Sell
40,900
-27,800
-40% -$318K ﹤0.01% 3164
2024
Q3 		$782K Buy
68,700
+60,600
+748% +$608K ﹤0.01% 2508
2024
Q2 		$57.8K Sell
8,100
-169,600
-95% -$1.3M ﹤0.01% 4414
2024
Q1 		$1.19M Buy
177,700
+175,800
+9,253% +$1.21M ﹤0.01% 1933
2023
Q4 		$12.3K Sell
1,900
-1,100
-37% -$7.09K ﹤0.01% 6073
2023
Q3 		$28.3K Sell
3,000
-29,500
-91% -$355K ﹤0.01% 5604
2023
Q2 		$454K Buy
32,500
+3,400
+12% +$58K ﹤0.01% 3122
2023
Q1 		$546K Buy
29,100
+25,900
+809% +$425K ﹤0.01% 2694
2022
Q4 		$44.1K Sell
3,200
-3,100
-49% -$47.5K ﹤0.01% 5090
2022
Q3 		$120K Sell
6,300
-3,000
-32% -$54.7K ﹤0.01% 4607
2022
Q2 		$142K Sell
9,300
-11,000
-54% -$163K ﹤0.01% 4647
2022
Q1 		$414K Buy
20,300
+7,700
+61% +$157K ﹤0.01% 4022
2021
Q4 		$368K Sell
12,600
-38,600
-75% -$1.1M ﹤0.01% 4462
2021
Q3 		$1.1M Buy
51,200
+45,800
+848% +$1.11M ﹤0.01% 3314
2021
Q2 		$139K Sell
5,400
-13,700
-72% -$293K ﹤0.01% 5620
2021
Q1 		$348K Sell
19,100
-46,900
-71% -$779K ﹤0.01% 4441
2020
Q4 		$762K Buy
66,000
+63,800
+2,900% +$583K ﹤0.01% 2893
2020
Q3 		$17K Sell
2,200
-7,800
-78% -$59.1K ﹤0.01% 5212
2020
Q2 		$66K Buy
10,000
+300
+3% +$1.68K ﹤0.01% 4190
2020
Q1 		$50K Sell
9,700
-7,400
-43% -$44.8K ﹤0.01% 3724
2019
Q4 		$131K Buy
17,100
+7,800
+84% +$45.5K ﹤0.01% 3470
2019
Q3 		$49K Sell
9,300
-8,700
-48% -$54K ﹤0.01% 3980
2019
Q2 		$101K Buy
18,000
+16,500
+1,100% +$68K ﹤0.01% 3343
2019
Q1 		$6K Sell
1,500
-4,500
-75% -$18.4K ﹤0.01% 4415
2018
Q4 		$25K Buy
6,000
+5,700
+1,900% +$29.7K ﹤0.01% 3928
2018
Q3 		$2K Sell
300
-9,300
-97% -$55.1K ﹤0.01% 5038
2018
Q2 		$38K Sell
9,600
-4,300
-31% -$14.9K ﹤0.01% 4099
2018
Q1 		$41K Sell
13,900
-11,100
-44% -$34.3K ﹤0.01% 3750
2017
Q4 		$97K Sell
25,000
-2,100
-8% -$8.99K ﹤0.01% 3377
2017
Q3 		$85K Buy
27,100
+25,200
+1,326% +$94.6K ﹤0.01% 3338
2017
Q2 		$8K Buy
1,900
+1,000
+111% +$4.09K ﹤0.01% 4298
2017
Q1 		$4K Buy
+900
New +$3.02K ﹤0.01% 4350
2016
Q3 		– Sell
-3,000
Closed -$8K – 4987
2016
Q2 		$8K Sell
3,000
-18,929
-86% -$52.8K ﹤0.01% 4155
2016
Q1 		$65K Buy
21,929
+14,815
+208% +$79.3K ﹤0.01% 3112
2015
Q4 		$58K Buy
7,114
+2,400
+51% +$19.4K ﹤0.01% 3326
2015
Q3 		$34K Sell
4,714
-4,443
-49% -$37.1K ﹤0.01% 3761
2015
Q2 		$84K Buy
9,157
+1,128
+14% +$10.8K ﹤0.01% 3199
2015
Q1 		$76K Sell
8,029
-8,771
-52% -$84.4K ﹤0.01% 3085
2014
Q4 		$163K Sell
16,800
-18,857
-53% -$190K ﹤0.01% 2465
2014
Q3 		$339K Buy
35,657
+19,300
+118% +$216K 0.01% 1925
2014
Q2 		$215K Sell
16,357
-22,729
-58% -$287K ﹤0.01% 2340
2014
Q1 		$520K Buy
39,086
+34,543
+760% +$455K 0.01% 1616
2013
Q4 		$44K Sell
4,543
-26,728
-85% -$251K ﹤0.01% 3725
2013
Q3 		$309K Sell
31,271
-34,143
-52% -$339K 0.01% 2014
2013
Q2 		$591K Buy
+65,414
New +$686K 0.01% 1207

Other funds holding CDMO

TCWM
Total Clarity Wealth Management St. Charles, Illinois $515M AUM 27.37% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Group One Trading's CDMO Position: Q1 2025 in Review

Group One Trading sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q1 2025, closing a stake of 3,338 shares — an estimated $41.2K sold.

Group One Trading first reported a position in CDMO in Q2 2013 and held it in 35 quarters. The position peaked at $252K in Q4 2021. 2 funds tracked by Wall St. Rank hold CDMO as of Q1 2025.

  • Group One Trading reported no remaining Avid Bioservices, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • Group One Trading sold 3,338 Avid Bioservices, Inc. Common Stock shares in Q1 2025, an estimated $41.2K.
  • Group One Trading first reported a position in Avid Bioservices, Inc. Common Stock in Q2 2013 and held it in 35 quarters.
  • Group One Trading's Avid Bioservices, Inc. Common Stock position peaked at $252K in Q4 2021.
  • 2 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q1 2025.

Based on Group One Trading's 13F filing for Q1 2025, filed 14 May 2025.